Tim Herbert
Herbert grew Inspire Medical from the ground up to $624MM in revenue but now contends with serious issues following an FDA recall of its only product.
While Herbert is widely respected for his leadership and ethics, his micromanagement and limited product range expose Inspire to risks.
Regulatory setbacks, legal challenges, and rising competitors create uncertainty around Inspire’s growth prospects in sleep apnea treatment.
By submitting this form, you are agreeing to ManagementTrack’s Privacy Policy. You can choose to opt out of marketing or advertising emails using the ‘unsubscibe’ link included in our emails.
The best
The best
The best
Our investigative journalists interview the top former colleagues of the CEOs you care about.
Our former buysider analysts summarize the key strengths & weaknesses, past successes & failures, and ability to drive value going forward.
You get access to the actual anonymized transcripts and insights.